
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 18/382805 | 2-[(1H-BENZIMIDAZOL-2-YL)IMINO]-5,5-DIPHENYLIMIDAZOLIDIN-4-ONE AS AN ANTIMICROBIAL COMPOUND | Oct 22, 2023 | Abandoned |
Array
(
[id] => 20452972
[patent_doc_number] => 12516022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Derivatives of aryl hydrocarbon receptor agonists
[patent_app_type] => utility
[patent_app_number] => 18/491686
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 27227
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491686
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491686 | Derivatives of aryl hydrocarbon receptor agonists | Oct 19, 2023 | Issued |
Array
(
[id] => 20452972
[patent_doc_number] => 12516022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Derivatives of aryl hydrocarbon receptor agonists
[patent_app_type] => utility
[patent_app_number] => 18/491686
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 27227
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491686
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491686 | Derivatives of aryl hydrocarbon receptor agonists | Oct 19, 2023 | Issued |
Array
(
[id] => 19083066
[patent_doc_number] => 20240109867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => ASK1 INHIBITING AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/377125
[patent_app_country] => US
[patent_app_date] => 2023-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18377125
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/377125 | ASK1 inhibiting agents | Oct 4, 2023 | Issued |
Array
(
[id] => 19034066
[patent_doc_number] => 20240083881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/372115
[patent_app_country] => US
[patent_app_date] => 2023-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18372115
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/372115 | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof | Sep 23, 2023 | Issued |
Array
(
[id] => 19020115
[patent_doc_number] => 20240076286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/468885
[patent_app_country] => US
[patent_app_date] => 2023-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18468885
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/468885 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | Sep 17, 2023 | Pending |
Array
(
[id] => 19020115
[patent_doc_number] => 20240076286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/468885
[patent_app_country] => US
[patent_app_date] => 2023-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18468885
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/468885 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | Sep 17, 2023 | Pending |
Array
(
[id] => 18902645
[patent_doc_number] => 20240018130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine
[patent_app_type] => utility
[patent_app_number] => 18/368362
[patent_app_country] => US
[patent_app_date] => 2023-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 436
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18368362
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/368362 | Pyrimidine derivative, method for preparing same and use thereof in medicine | Sep 13, 2023 | Issued |
Array
(
[id] => 18902645
[patent_doc_number] => 20240018130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine
[patent_app_type] => utility
[patent_app_number] => 18/368362
[patent_app_country] => US
[patent_app_date] => 2023-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 436
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18368362
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/368362 | Pyrimidine derivative, method for preparing same and use thereof in medicine | Sep 13, 2023 | Issued |
Array
(
[id] => 18902645
[patent_doc_number] => 20240018130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine
[patent_app_type] => utility
[patent_app_number] => 18/368362
[patent_app_country] => US
[patent_app_date] => 2023-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 436
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18368362
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/368362 | Pyrimidine derivative, method for preparing same and use thereof in medicine | Sep 13, 2023 | Issued |
Array
(
[id] => 19043556
[patent_doc_number] => 11932640
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-03-19
[patent_title] => Pyrrolo[3,4-b]quinoline compounds as antibacterial agents
[patent_app_type] => utility
[patent_app_number] => 18/244644
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9384
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244644
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/244644 | Pyrrolo[3,4-b]quinoline compounds as antibacterial agents | Sep 10, 2023 | Issued |
Array
(
[id] => 18861800
[patent_doc_number] => 20230416235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/244281
[patent_app_country] => US
[patent_app_date] => 2023-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244281
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/244281 | Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof | Sep 9, 2023 | Issued |
Array
(
[id] => 19034069
[patent_doc_number] => 20240083884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOUNDS AND METHOD FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/463112
[patent_app_country] => US
[patent_app_date] => 2023-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463112
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463112 | COMPOUNDS AND METHOD FOR PREPARING THE SAME | Sep 6, 2023 | Pending |
Array
(
[id] => 19034069
[patent_doc_number] => 20240083884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOUNDS AND METHOD FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/463112
[patent_app_country] => US
[patent_app_date] => 2023-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463112
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463112 | COMPOUNDS AND METHOD FOR PREPARING THE SAME | Sep 6, 2023 | Pending |
Array
(
[id] => 19076468
[patent_doc_number] => 11945818
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-02
[patent_title] => Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/242753
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9665
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242753
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/242753 | Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors | Sep 5, 2023 | Issued |
Array
(
[id] => 19380851
[patent_doc_number] => 20240270721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/461179
[patent_app_country] => US
[patent_app_date] => 2023-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461179
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/461179 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Sep 4, 2023 | Pending |
Array
(
[id] => 19135557
[patent_doc_number] => 11970487
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-30
[patent_title] => 7-(4-((5-(benzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2h)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound
[patent_app_type] => utility
[patent_app_number] => 18/241383
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4214
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18241383
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/241383 | 7-(4-((5-(benzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2h)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound | Aug 31, 2023 | Issued |
Array
(
[id] => 19067104
[patent_doc_number] => 20240101530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => HDAC INHIBITOR SOLID STATE FORMS
[patent_app_type] => utility
[patent_app_number] => 18/240853
[patent_app_country] => US
[patent_app_date] => 2023-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18240853
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/240853 | HDAC INHIBITOR SOLID STATE FORMS | Aug 30, 2023 | Abandoned |
Array
(
[id] => 20372405
[patent_doc_number] => 12479827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/455865
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46856
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455865
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455865 | Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors | Aug 24, 2023 | Issued |
Array
(
[id] => 18948099
[patent_doc_number] => 11891380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Solid state forms of Belumosudil and Belumosudil salts
[patent_app_type] => utility
[patent_app_number] => 18/236458
[patent_app_country] => US
[patent_app_date] => 2023-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 16904
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18236458
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/236458 | Solid state forms of Belumosudil and Belumosudil salts | Aug 21, 2023 | Issued |